StockData

NanoViricides, Inc. (NNVC) stock

NNVCNYSEPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$1.19+0.03 (+2.59%)

Close on Nov 18, 2026Market cap $30.37MP/E –Yield –

NanoViricides shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

NanoViricides's shares outstanding was 22M at Jun 30, 2026. For fiscal 2026 it was 20M, up 33.5% from the year before. Over ten years it grew 21.5% a year on average. The highest annual figure on record is 20M in fiscal 2026.

Annual shares outstanding

PeriodPeriod endValueChange
FY2026Jun 30, 202620M+33.5%
FY2025Jun 30, 202515M+27.3%
FY2024Jun 30, 202412M+2.1%
FY2023Jun 30, 202312M+0.8%
FY2022Jun 30, 202212M+5.8%
FY2021Jun 30, 202111M+94.1%
FY2020Jun 30, 20206M+56.5%
FY2019Jun 30, 20194M+10.6%
FY2018Jun 30, 20183M+8.0%
FY2017Jun 30, 20173M+4.2%
FY2016Jun 30, 20163M-2.6%
FY2015Jun 30, 20153M+15.6%
FY2014Jun 30, 20143M+7.6%
FY2013Jun 30, 20132M+11.3%
FY2012Jun 30, 20122M+7.5%
FY2011Jun 30, 20112M+6.7%
FY2010Jun 30, 20102M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 202622M+37.5%
Q3 FY2026CQ1 2026Mar 31, 202622M+34.8%
Q2 FY2026CQ4 2025Dec 31, 202520M+36.2%
Q1 FY2026CQ3 2025Sep 30, 202517M+24.5%
Q4 FY2025CQ2 2025Jun 30, 202516M+32.2%
Q3 FY2025CQ1 2025Mar 31, 202516M+36.1%
Q2 FY2025CQ4 2024Dec 31, 202415M+24.1%
Q1 FY2025CQ3 2024Sep 30, 202414M+17.0%
Q4 FY2024CQ2 2024Jun 30, 202412M+4.9%
Q3 FY2024CQ1 2024Mar 31, 202412M+1.2%
Q2 FY2024CQ4 2023Dec 31, 202312M+1.2%
Q1 FY2024CQ3 2023Sep 30, 202312M+1.1%
Q4 FY2023CQ2 2023Jun 30, 202312M+0.9%
Q3 FY2023CQ1 2023Mar 31, 202312M+0.8%
Q2 FY2023CQ4 2022Dec 31, 202212M+0.7%
Q1 FY2023CQ3 2022Sep 30, 202212M+0.7%
Q4 FY2022CQ2 2022Jun 30, 202212M+0.5%
Q3 FY2022CQ1 2022Mar 31, 202212M+5.4%
Q2 FY2022CQ4 2021Dec 31, 202112M+8.1%
Q1 FY2022CQ3 2021Sep 30, 202112M+9.8%
Q4 FY2021CQ2 2021Jun 30, 202112M+39.1%
Q3 FY2021CQ1 2021Mar 31, 202111M+68.0%
Q2 FY2021CQ4 2020Dec 31, 202011M+176.8%
Q1 FY2021CQ3 2020Sep 30, 202010M+172.8%
Q4 FY2020CQ2 2020Jun 30, 20208M+115.6%
Q3 FY2020CQ1 2020Mar 31, 20207M+81.2%
Q2 FY2020CQ4 2019Dec 31, 20194M+11.1%
Q1 FY2020CQ3 2019Sep 30, 20194M+11.2%
Q4 FY2019CQ2 2019Jun 30, 20194M+11.2%
Q3 FY2019CQ1 2019Mar 31, 20194M+12.3%
Q2 FY2019CQ4 2018Dec 31, 20183M+9.5%
Q1 FY2019CQ3 2018Sep 30, 20183M+9.3%
Q4 FY2018CQ2 2018Jun 30, 20183M+9.4%
Q3 FY2018CQ1 2018Mar 31, 20183M+5.0%
Q2 FY2018CQ4 2017Dec 31, 20173M+8.8%
Q1 FY2018CQ3 2017Sep 30, 20173M+8.8%
Q4 FY2017CQ2 2017Jun 30, 20173M–
Q3 FY2017CQ1 2017Mar 31, 20173M–
Q2 FY2017CQ4 2016Dec 31, 20163M–
Q1 FY2017CQ3 2016Sep 30, 20163M–

More NanoViricides figures

See a number that looks wrong?